NYSE: NUVB - Nuvation Bio Inc.

Yield per half year: -24.9%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Nuvation Bio Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Nuvation Bio Inc.

Nuvation Bio Inc., биофармацевтическая компания, работающая на клинической стадии, специализируется на разработке терапевтических кандидатов для онкологии. Основным кандидатом на продукцию компании является NUV-422, низкомолекулярный ингибитор, нацеленный на CDK2, CDK4 и CDK6.

more details
Он также разрабатывает NUV-868, селективный ингибитор семейства эпигенетических регуляторов транскрипции BET; NUV-569, дифференцированный селективный ингибитор киназы Wee1; NUV-1182, ингибитор аденозинового рецептора; и платформа DDC, которая фокусируется на нацеливании ингибитора поли-АДФ-рибозной полимеразы (PARP) на раковые клетки, экспрессирующие андрогенный рецептор, а также ингибитора PARP на экспрессирующие ER раковые клетки. Ранее компания была известна как RePharmation Inc. и сменила название на Nuvation Bio Inc. в апреле 2019 года. Nuvation Bio Inc. была зарегистрирована в 2018 году, ее штаб-квартира находится в Нью-Йорке, штат Нью-Йорк.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2020-08-24
ISIN US67080N1019
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт http://www.nuvationbio.com
Цена ао 1.86
Change price per day: -4.38% (1.94)
Change price per week: -6.31% (1.98)
Change price per month: -10.82% (2.08)
Change price per 3 month: -34.22% (2.82)
Change price per half year: -24.9% (2.47)
Change price per year: -35.59% (2.88)
Change price per 3 year: -65.39% (5.36)
Change price per year to date: -29.2% (2.62)
All parameters

Underestimation

Title Value Grade
P/S -421.42 0
P/BV 0.539 10
P/E 0 0
EV/EBITDA -2.89 0
Total: 3.63

Efficiency

Title Value Grade
ROA, % -12.2 0
ROE, % -12.53 0
Total: 3.33

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.0402 10
Total: 8.4

Growth impulse

Title Value Grade
Yield Revenue, % 27.52 4
Yield Ebitda, % 311150 10
Yield EPS, % 113.38 10
Total: 8.8
More

Institutions Volume Share, %
FMR, LLC 26130659 11.98
EcoR1 Capital, LLC 19209643 8.81
Omega Fund Management, Llc 15072340 6.91
Blackrock Inc. 12882429 5.91
Vanguard Group Inc 7314615 3.35
Abrams Capital Management, L.P. 3811513 1.75
Tang Capital Management, LLC 3500000 1.61
Millennium Management LLC 3094669 1.42
State Street Corporation 3062214 1.4
Geode Capital Management, LLC 3046325 1.4

ETFShare, %Profitability for 1 year, %Dividends, %
Range Cancer Therapeutics ETF 1.80964 47.24 0.11955
Morgan Creek - Exos SPAC Originated ETF 1.42 0
Virtus LifeSci Biotech Clinical Trials ETF 0.74154 63.04 0.33
SPDR S&P Pharmaceuticals ETF 0.58071 29.8 1.29889
Direxion Daily Pharmaceutical & Medical Bull 3X Shares 0.28791 86.72 1.2989
iShares U.S. Pharmaceuticals ETF 0.18272 6.09 1.97922
iShares Micro-Cap ETF 0.12897 17.09 1.54048
Avantis U.S Small Cap Equity ETF 0.06663 27.77 1.68271
iShares ESG Aware MSCI USA Small-Cap ETF 0.0468 18.09 1.49366
Invesco FTSE RAFI US 1500 Small-Mid ETF 0.03105 17.58 1.75869
Nuveen ESG Small-Cap ETF 0.02545 13.91 1.41019
Vanguard Russell 2000 ETF 0.02 17.16 1.48801
iShares Morningstar Small Cap Value ETF 0.01674 26.7 2.50476
iShares Morningstar Small-Cap Value ETF 0.01674 201.65 2.50476
Schwab U.S. Small-Cap ETF 0.01331 17.47 1.51433
Dimensional U.S. Targeted Value ETF 0.01091 26.01 1.93487
ProShares UltraPro Russell2000 0.01086 89.82 1.47873
iShares Morningstar Small-Cap ETF 0.00826 30.1 1.60498
iShares Morningstar Small-Cap ETF 0.00826 391.25 1.60498
Fidelity MSCI Health Care Index ETF 0.00717 3 1.46057
Dimensional U.S. Core Equity 2 ETF 0.00441 30.76 1.47098
SPDR Portfolio MSCI Global Stock Market ETF 0.00373 17.99 2.19607
Humankind US Stock ETF 0.00323 18.81 1.99919
ProShares Hedge Replication ETF 0.00318 5.92 1.47892
Dimensional US Core Equity Market ETF 0.00151 30.98 1.40618
Avantis U.S. Equity ETF 0.00132 23.04 1.59151
iShares Russell 3000 ETF 0.00088 24.83 1.43482
Schwab U.S. Broad Market ETF 0.00074 24.86 1.43354
Dimensional U.S. Equity ETF 0.00065 31.53 1.3557
Vanguard Russell 3000 ETF 0 31.87 1.43817
0.1845.71.49



Head Job title Payment Year of birth
Dr. David T. Hung M.D. Founder, President, CEO & Chairman 944.51k 1958 (67 years)
Ms. Stacy Markel Chief People Officer N/A 1965 (60 years)
Dr. Gary Hattersley Ph.D. Chief Scientific Officer 687.88k 1967 (58 years)
Ms. Kerry A. Wentworth Chief Regulatory Officer N/A 1973 (52 years)
Dr. David Liu M.D., Ph.D. Chief Medical Officer N/A 1970 (55 years)
Dr. David C. Hanley Ph.D. Chief Technical Operations Officer 586.04k 1970 (55 years)
Mr. Moses Makunje CPA VP of Finance and Principal Accounting & Financial Officer 1979 (46 years)
Stephen Dang VP of Legal & Secretary
Ms. Colleen Sjogren Chief Commercial Officer 1970 (55 years)
Dr. Junyuan Wang Ph.D. CEO & Co-Founder of AnHeart Therapeutics and Director 1973 (52 years)

Address: United States, New York, NY , 1500 Broadway - open in Google maps, open in Yandex maps
Website: http://www.nuvationbio.com